Travere Therapeutics (TVTX) Total Debt Growth (1y) (2014 - 2023)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Debt Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - | - |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn | 5.94% |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - | 103.99% |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn | - |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn | 0.07% |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn | - |
| 10 | Travere Therapeutics | 4.34 Bn | 4.26 Bn | 102.38 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2023 | -5.48% |
| Mar 31, 2023 | -8.00% |
| Dec 31, 2022 | -5.41% |
| Dec 31, 2021 | -57.47% |
| Dec 31, 2018 | 42.95% |
| Sep 30, 2018 | 11.11% |
| Jun 30, 2018 | 102.14% |
| Dec 31, 2017 | -29.99% |
| Sep 30, 2017 | -30.46% |
| Jun 30, 2017 | -32.67% |
| Mar 31, 2017 | -13.45% |
| Dec 31, 2016 | -42.18% |
| Sep 30, 2016 | -31.24% |
| Jun 30, 2016 | -63.42% |
| Mar 31, 2016 | -76.51% |
| Dec 31, 2015 | 38.66% |
| Sep 30, 2015 | -28.17% |
| Jun 30, 2015 | 102.67% |
| Dec 31, 2014 | 11.79% |